{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:20:01Z","timestamp":1790230801199,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T00:00:00Z","timestamp":1496448000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10741-017-9628-1","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T01:31:02Z","timestamp":1496453462000},"page":"455-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies"],"prefix":"10.1007","volume":"22","author":[{"given":"Paco E.","family":"Bravo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F.","family":"Di Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,3]]},"reference":[{"key":"9628_CR1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.115.305364","volume":"118","author":"DD Gutterman","year":"2016","unstructured":"Gutterman DD, Chabowski DS, Kadlec AO, Durand MJ, Freed JK, Ait-Aissa K et al (2016) The human microcirculation: regulation of flow and beyond. Circ res 118:157\u2013172","journal-title":"Circ res"},{"key":"9628_CR2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/heartjnl-2013-304291","volume":"100","author":"R Spoladore","year":"2014","unstructured":"Spoladore R, Fisicaro A, Faccini A, Camici PG (2014) Coronary microvascular dysfunction in primary cardiomyopathies. Heart 100:806\u2013813","journal-title":"Heart"},{"key":"9628_CR3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"PG Camici","year":"2007","unstructured":"Camici PG, Crea F (2007) Coronary microvascular dysfunction. N Engl J med 356:830\u2013840","journal-title":"N Engl J med"},{"key":"9628_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9149(83)80088-5","volume":"51","author":"F Schwarz","year":"1983","unstructured":"Schwarz F, Mall G, Zebe H, Blickle J, Derks H, Manthey J et al (1983) Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol 51:501\u2013506","journal-title":"Am J Cardiol"},{"key":"9628_CR5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.RES.87.8.644","volume":"87","author":"D Abraham","year":"2000","unstructured":"Abraham D, Hofbauer R, Schafer R, Blumer R, Paulus P, Miksovsky A et al (2000) Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ res 87:644\u2013647","journal-title":"Circ res"},{"key":"9628_CR6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.84.1.203","volume":"84","author":"M Mosseri","year":"1991","unstructured":"Mosseri M, Schaper J, Admon D, Hasin Y, Gotsman MS, Sapoznikov D et al (1991) Coronary capillaries in patients with congestive cardiomyopathy or angina pectoris with patent main coronary arteries. Ultrastructural morphometry of endomyocardial biopsy samples. Circulation 84:203\u2013210","journal-title":"Circulation"},{"key":"9628_CR7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/01.CIR.92.4.796","volume":"92","author":"D Neglia","year":"1995","unstructured":"Neglia D, Parodi O, Gallopin M, Sambuceti G, Giorgetti A, Pratali L et al (1995) Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation 92:796\u2013804","journal-title":"Circulation"},{"key":"9628_CR8","first-page":"837","volume":"41","author":"AE Drzezga","year":"2000","unstructured":"Drzezga AE, Blasini R, Ziegler SI, Bengel FM, Picker W, Schwaiger M (2000) Coronary microvascular reactivity to sympathetic stimulation in patients with idiopathic dilated cardiomyopathy. J Nucl med 41:837\u2013844","journal-title":"J Nucl med"},{"key":"9628_CR9","first-page":"414","volume":"45","author":"B Nowak","year":"2004","unstructured":"Nowak B, Stellbrink C, Schaefer WM, Sinha AM, Breithardt OA, Kaiser HJ et al (2004) Comparison of regional myocardial blood flow and perfusion in dilated cardiomyopathy and left bundle branch block: role of wall thickening. J Nucl med 45:414\u2013418","journal-title":"J Nucl med"},{"key":"9628_CR10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.CIR.85.3.1125","volume":"85","author":"S Ono","year":"1992","unstructured":"Ono S, Nohara R, Kambara H, Okuda K, Kawai C (1992) Regional myocardial perfusion and glucose metabolism in experimental left bundle branch block. Circulation 85:1125\u20131131","journal-title":"Circulation"},{"key":"9628_CR11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/CIRCIMAGING.109.934638","volume":"3","author":"PG Masci","year":"2010","unstructured":"Masci PG, Marinelli M, Piacenti M, Lorenzoni V, Positano V, Lombardi M et al (2010) Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study. Circ Cardiovasc Imaging 3:482\u2013490","journal-title":"Circ Cardiovasc Imaging"},{"key":"9628_CR12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/ehjci\/jev012","volume":"16","author":"MD Majmudar","year":"2015","unstructured":"Majmudar MD, Murthy VL, Shah RV, Kolli S, Mousavi N, Foster CR et al (2015) Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging 16:900\u2013909","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"9628_CR13","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1161\/01.CIR.0000017433.90061.2E","volume":"105","author":"LA Nikolaidis","year":"2002","unstructured":"Nikolaidis LA, Doverspike A, Huerbin R, Hentosz T, Shannon RP (2002) Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation 105:2785\u20132790","journal-title":"Circulation"},{"key":"9628_CR14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jacc.2004.10.019","volume":"45","author":"K Sugioka","year":"2005","unstructured":"Sugioka K, Hozumi T, Takemoto Y, Ujino K, Matsumura Y, Watanabe H et al (2005) Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study. J am Coll Cardiol 45:318\u2013319","journal-title":"J am Coll Cardiol"},{"key":"9628_CR15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.CIR.0000138108.68719.C1","volume":"110","author":"P Knaapen","year":"2004","unstructured":"Knaapen P, van Campen LM, de Cock CC, Gotte MJ, Visser CA, Lammertsma AA et al (2004) Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 110:646\u2013651","journal-title":"Circulation"},{"key":"9628_CR16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0735-1097(93)90193-5","volume":"22","author":"V Dilsizian","year":"1993","unstructured":"Dilsizian V, Bonow RO, Epstein SE, Fananapazir L (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J am Coll Cardiol 22:796\u2013804","journal-title":"J am Coll Cardiol"},{"key":"9628_CR17","doi-asserted-by":"crossref","first-page":"H986","DOI":"10.1152\/ajpheart.00233.2007","volume":"294","author":"P Knaapen","year":"2008","unstructured":"Knaapen P, Germans T, Camici PG, Rimoldi OE, ten Cate FJ, ten Berg JM et al (2008) Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 294:H986\u2013H993","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9628_CR18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.75.6.1130","volume":"75","author":"M Tanaka","year":"1987","unstructured":"Tanaka M, Fujiwara H, Onodera T, Wu DJ, Matsuda M, Hamashima Y et al (1987) Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 75:1130\u20131139","journal-title":"Circulation"},{"key":"9628_CR19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","volume":"8","author":"BJ Maron","year":"1986","unstructured":"Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy. J am Coll Cardiol 8:545\u2013557","journal-title":"J am Coll Cardiol"},{"key":"9628_CR20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/eurjhf\/hfr135","volume":"13","author":"SA Timmer","year":"2011","unstructured":"Timmer SA, Germans T, Brouwer WP, Lubberink M, van der Velden J, Wilde AA et al (2011) Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction. Eur J Heart Fail 13:1283\u20131289","journal-title":"Eur J Heart Fail"},{"key":"9628_CR21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2967\/jnumed.111.096156","volume":"53","author":"PE Bravo","year":"2012","unstructured":"Bravo PE, Pinheiro A, Higuchi T, Rischpler C, Merrill J, Santaularia-Tomas M et al (2012) PET\/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 53:407\u2013414","journal-title":"Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine"},{"key":"9628_CR22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","volume":"58","author":"I Olivotto","year":"2011","unstructured":"Olivotto I, Girolami F, Sciagra R, Ackerman MJ, Sotgia B, Bos JM et al (2011) Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J am Coll Cardiol 58:839\u2013848","journal-title":"J am Coll Cardiol"},{"key":"9628_CR23","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","volume":"115","author":"SE Petersen","year":"2007","unstructured":"Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA et al (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115:2418\u20132425","journal-title":"Circulation"},{"key":"9628_CR24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/heart.84.5.476","volume":"84","author":"AM Varnava","year":"2000","unstructured":"Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476\u2013482","journal-title":"Heart"},{"key":"9628_CR25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.97.3.230","volume":"97","author":"R Krams","year":"1998","unstructured":"Krams R, Kofflard MJ, Duncker DJ, Von Birgelen C, Carlier S, Kliffen M et al (1998) Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 97:230\u2013233","journal-title":"Circulation"},{"key":"9628_CR26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0735-1097(91)90869-B","volume":"17","author":"P Camici","year":"1991","unstructured":"Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G et al (1991) Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J am Coll Cardiol 17:879\u2013886","journal-title":"J am Coll Cardiol"},{"key":"9628_CR27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2967\/jnumed.107.050138","volume":"49","author":"B Sotgia","year":"2008","unstructured":"Sotgia B, Sciagra R, Olivotto I, Casolo G, Rega L, Betti I et al (2008) Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 49:1090\u20131096","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine."},{"key":"9628_CR28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCIMAGING.112.000110","volume":"6","author":"PE Bravo","year":"2013","unstructured":"Bravo PE, Zimmerman SL, Luo HC, Pozios I, Rajaram M, Pinheiro A et al (2013) Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circulation Cardiovascular Imaging 6:210\u2013217","journal-title":"Circulation Cardiovascular Imaging"},{"key":"9628_CR29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","volume":"349","author":"F Cecchi","year":"2003","unstructured":"Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J med 349:1027\u20131035","journal-title":"N Engl J med"},{"key":"9628_CR30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","volume":"47","author":"I Olivotto","year":"2006","unstructured":"Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F et al (2006) Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J am Coll Cardiol 47:1043\u20131048","journal-title":"J am Coll Cardiol"},{"key":"9628_CR31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2016.06.026","volume":"68","author":"AJ Marian","year":"2016","unstructured":"Marian AJ (2016) Challenges in the diagnosis of Anderson-Fabry disease: a deceptively simple and yet complicated genetic disease. J am Coll Cardiol 68:1051\u20131053","journal-title":"J am Coll Cardiol"},{"key":"9628_CR32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","volume":"93","author":"A Linhart","year":"2007","unstructured":"Linhart A, Elliott PM (2007) The heart in Anderson-Fabry disease and other lysosomal storage disorders. Heart 93:528\u2013535","journal-title":"Heart"},{"key":"9628_CR33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/eurjhf\/hft104","volume":"15","author":"B Tomberli","year":"2013","unstructured":"Tomberli B, Cecchi F, Sciagra R, Berti V, Lisi F, Torricelli F et al (2013) Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. Eur J Heart Fail 15:1363\u20131373","journal-title":"Eur J Heart Fail"},{"key":"9628_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.carpath.2009.10.003","volume":"20","author":"MN Sheppard","year":"2011","unstructured":"Sheppard MN (2011) The heart in Fabry\u2019s disease. Cardiovasc Pathol 20:8\u201314","journal-title":"Cardiovasc Pathol"},{"key":"9628_CR35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10545-008-0794-0","volume":"31","author":"T Kovarnik","year":"2008","unstructured":"Kovarnik T, Mintz GS, Karetova D, Horak J, Bultas J, Skulec R et al (2008) Intravascular ultrasound assessment of coronary artery involvement in Fabry disease. J Inherit Metab dis 31:753\u2013760","journal-title":"J Inherit Metab dis"},{"key":"9628_CR36","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","volume":"28","author":"A Linhart","year":"2007","unstructured":"Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A et al (2007) Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J 28:1228\u20131235","journal-title":"Eur Heart J"},{"key":"9628_CR37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10545-005-0563-2","volume":"28","author":"RJ Kalliokoski","year":"2005","unstructured":"Kalliokoski RJ, Kalliokoski KK, Sundell J, Engblom E, Penttinen M, Kantola I et al (2005) Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease. J Inherit Metab dis 28:563\u2013573","journal-title":"J Inherit Metab dis"},{"key":"9628_CR38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.2004.054015","volume":"92","author":"PM Elliott","year":"2006","unstructured":"Elliott PM, Kindler H, Shah JS, Sachdev B, Rimoldi OE, Thaman R et al (2006) Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A. Heart 92:357\u2013360","journal-title":"Heart"},{"key":"9628_CR39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10545-006-0221-3","volume":"29","author":"RJ Kalliokoski","year":"2006","unstructured":"Kalliokoski RJ, Kantola I, Kalliokoski KK, Engblom E, Sundell J, Hannukainen JC et al (2006) The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease. J Inherit Metab dis 29:112\u2013118","journal-title":"J Inherit Metab dis"},{"key":"9628_CR40","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10545-008-0848-3","volume":"31","author":"JW Koskenvuo","year":"2008","unstructured":"Koskenvuo JW, Hartiala JJ, Nuutila P, Kalliokoski R, Viikari JS, Engblom E et al (2008) Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters. J Inherit Metab dis 31:432\u2013441","journal-title":"J Inherit Metab dis"},{"key":"9628_CR41","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","volume":"68","author":"RH Falk","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S (2016) AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy. J am Coll Cardiol 68:1323\u20131341","journal-title":"J am Coll Cardiol"},{"key":"9628_CR42","doi-asserted-by":"crossref","first-page":"838","DOI":"10.7326\/0003-4819-131-11-199912070-00007","volume":"131","author":"J Suwaidi Al","year":"1999","unstructured":"Al Suwaidi J, Velianou JL, Gertz MA, Cannon RO 3rd, Higano ST, Holmes DR Jr et al (1999) Systemic amyloidosis presenting with angina pectoris. Ann Intern med 131:838\u2013841","journal-title":"Ann Intern med"},{"key":"9628_CR43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","volume":"2","author":"S Dorbala","year":"2014","unstructured":"Dorbala S, Vangala D, Bruyere J Jr, Quarta C, Kruger J, Padera R et al (2014) Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail 2:358\u2013367","journal-title":"JACC Heart Fail"},{"key":"9628_CR44","first-page":"1287","volume":"118","author":"MA Neben-Wittich","year":"2005","unstructured":"Neben-Wittich MA, Wittich CM, Mueller PS, Larson DR, Gertz MA, Edwards WD (2005) Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. Am J med 118:1287","journal-title":"Am J med"},{"key":"9628_CR45","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehm066","volume":"28","author":"KM Modesto","year":"2007","unstructured":"Modesto KM, Dispenzieri A, Gertz M, Cauduro SA, Khandheria BK, Seward JB et al (2007) Vascular abnormalities in primary amyloidosis. Eur Heart J 28:1019\u20131024","journal-title":"Eur Heart J"},{"key":"9628_CR46","doi-asserted-by":"crossref","first-page":"H2305","DOI":"10.1152\/ajpheart.00503.2011","volume":"301","author":"RQ Migrino","year":"2011","unstructured":"Migrino RQ, Truran S, Gutterman DD, Franco DA, Bright M, Schlundt B et al (2011) Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol 301:H2305\u2013H2312","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9628_CR47","doi-asserted-by":"crossref","unstructured":"Dorbala S, Vangala D, Bruyere J Jr, Quarta C, Kruger J, Padera R et al (2014) Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Failure","DOI":"10.1016\/j.jchf.2014.03.009"},{"key":"9628_CR48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0735-1097(99)00499-4","volume":"35","author":"AF Heuvel van den","year":"2000","unstructured":"van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM et al (2000) Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J am Coll Cardiol 35:19\u201328","journal-title":"J am Coll Cardiol"},{"key":"9628_CR49","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.108.055665","volume":"50","author":"FT Range","year":"2009","unstructured":"Range FT, Paul M, Schafers KP, Acil T, Kies P, Hermann S et al (2009) Myocardial perfusion in nonischemic dilated cardiomyopathy with and without atrial fibrillation. J Nucl med 50:390\u2013396","journal-title":"J Nucl med"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-017-9628-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-017-9628-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-017-9628-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T08:39:08Z","timestamp":1498120748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-017-9628-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,3]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["9628"],"URL":"https:\/\/doi.org\/10.1007\/s10741-017-9628-1","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,3]]}}}